Ponatinib

CHEMBL1171837 Phase 4 Disetujui Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

532.6 g/mol

LogP

4.1

Phase

4

A targeted therapy used to treat certain types of leukemia, particularly chronic myeloid leukemia and acute lymphoblastic leukemia, especially in patients whose cancer carries a specific genetic mutation called T315I that makes other similar medications ineffective. It works by blocking proteins that drive the uncontrolled growth of leukemia cells.

Berat Molekul

532,6000 g/mol

LogP

4,10

TPSA

65,80 Å²

Lipinski RO5

Lulus

Area Terapeutik

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Non-Small Cell Lung Cancer Lymphoma Breast Cancer Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Struktur 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12

InChI

InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)

Molecular Formula

C29H27F3N6O

HBD / HBA

1 / 8

Ikatan yang Dapat Dirotasi

6

Atom Berat

39

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A targeted therapy used to treat certain types of leukemia, particularly chronic myeloid leukemia and acute lymphoblastic leukemia, especially in patients whose cancer carries a specific genetic mutation called T315I that makes other similar medications ineffective. It works by blocking proteins that drive the uncontrolled growth of leukemia cells.

Yes, Ponatinib is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1171837. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24826799. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Mencari informasi yang ramah bagi pasien?

Ponatinib di PillFYI

Struktur

Data Cepat

Rumus: C29H27F3N6O
Sinonim: 1

Tautan Eksternal

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.